eTheRNA immunotherapies NV, a clinical-stage company developing mRNA-based immunotherapies with in-house GMP certified production and process development capabilities, and Quantoom Biosciences S.A., a biotech company aiming to improve access to essential medicines through innovative bioproduction methods, are set to collaborate on the development of an RNA production system (RPS) for both research and GMP-grade material.   Quantoom and eTheRNA will work together to build an advanced, small foo...